Medication safety and the administration of intravenous vincristine: international survey of oncology pharmacists.
Approach to Improving Safety
Setting of Care
The chemotherapy drug vincristine almost always causes fatal toxicity if it is incorrectly administered intrathecally (via spinal injection) rather than intravenously. This hazard is well publicized, but accidental administration of intrathecal vincristine continues to occur. This survey of oncology pharmacists found that many pharmacies still lack appropriate safeguards to prevent such errors.